Foundayo (Orforglipron) Foundayo, approved in April 2026, offers patients a flexible oral option
Tuy nhin, nu c bt k phn ng bt thng no, hy ngng s dng v tham kho kin bc s
Key points: GLP-1 and GIP are hormones released by the body after we eat food They communicate directly with the brain to lower hunger and food-seeking behaviours Wegovy is a single-action weight-loss injection and mimics the actions of the GLP-1 hormone Wegovys active ingredient is semaglutide and is manufactured by Novo Nordisk Zepbound is a dual-action weight-loss injection and mimics the actions of the hormones GLP-1 and GIP Zepbounds active ingredient is tirzepatide, and its manufactured by Eli Lilly 2) Do you lose more weight on Zepbound or Wegovy
Thats why were actively stockpiling GLP-1 receptor agonists for our patients in our 6-month weight management program, so theyll have access to the medication during their program, and if supplies last, well after their 6-month program
In large trials, people continued losing weight for many months, but progress started to level off after about a year, with weight stabilizing around that point
The combined entity is a formidable potential acquirer for many early-stage digital health companies, but new entrants to the market will also have to answer the question around why cant Telavongo build this?, which will be difficult to answer, says Cheatham
